2011-05-13T14:29:42-05:00 2010-06-30 ERNST & YOUNG US LLP 75 BEATTIE PLACE SUITE 800 GREENVILLE SC 29601 990 2009-07-01 592451713 H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC HLEE 8137454673 12902 MAGNOLIA DRIVE TAMPA FL 33612 JANENE CULUMBER 8137451329 2011-05-13 8642425740 2009 2016-02-24 21:20:13Z JANENE CULUMBER 12902 MAGNOLIA DRIVE TAMPA FL 33612 98428458 0 X WWW.MOFFITT.ORG X 1984 FL TO PROMOTE AND SUPPORT THROUGH RESEARCH, MANAGEMENT AND OTHER MEANS OF SUPPORT. 20 18 1400 40 42103 0 116278541 94099419 1539033 3691373 330583 64234 668247 532987 118816404 98388013 3283 20550 0 72188070 75041589 0 0 51592525 49737222 123783878 124799361 -4967474 -26411348 287041137 286521048 254850182 253605994 32190955 32915054 TO PROMOTE AND SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, AND H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION THROUGH RESEARCH, MANAGEMENT AND OTHER MEANS OF SUPPORT. 0 0 94770542 20550 3786599 THE MISSION OF THE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. IS TO CONTRIBUTE TO THE PREVENTION AND CURE OF CANCER. THE CANCER CENTER IS A RECOGNIZED LEADER IN FOCUSED, INNOVATIVE CANCER RESEARCH, A MAJOR REGIONAL ONCOLOGY REFERRAL CENTER, AND A NATIONAL CANCER INSTITUTE DESIGNATED COMPREHENSIVE CANCER CENTER.THE CANCER CENTER'S ACTIVITIES RELATE PRIMARILY TO RESEARCH IN THE AREAS OF BASIC SCIENCE, CANCER PREVENTION AND CONTROL, TRANSLATIONAL SCIENCE, PRE-CLINICAL AND CLINICAL INVESTIGATIONS, AND PROVIDING MANAGEMENT AND CERTAIN OTHER SUPPORT SERVICES AS THE SOLE CORPORATE MEMBER AND PARENT FOR THE FOLLOWING SUBSIDIARY CORPORATIONS: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. (THE HOSPITAL) WHICH PROVIDES MEDICAL AND HOSPITAL CARE, MEDICAL EDUCATION AND TRAINING, AND CLINICAL (PATIENT-RELATED) RESEARCH IN MAINTAINING HEALTH, AND PREVENTING, DETECTING, AND TREATING CANCER;H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. (MOFFITT MEDICAL GROUP) WHICH EMPLOYS AND MANAGES PHYSICIANS AND OTHER MEDICAL PROFESSIONALS WHO STAFF THE HOSPITAL, AND PROVIDE CLINICAL RESEARCH SERVICES TO THE CANCER CENTER; ANDH. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. (THE FOUNDATION) WHICH IS THE PRINCIPAL FUND-RAISING ORGANIZATION FOR THE CANCER CENTER AND ITS SUBSIDIARIES.THE CANCER CENTER'S MULTIDISCIPLINARY CLINICAL PROGRAM STRUCTURE AND OPEN LABORATORY ARCHITECTURE PROVIDE A CONDUCIVE ENVIRONMENT FOR TRAINING FUTURE SCIENTIFIC AND CLINICAL LEADERS IN ONCOLOGY AND REFLECT THE CANCER CENTER'S COMMITMENT TO COLLABORATION IN ALL ASPECTS OF CANCER RESEARCH. 94770542 1 1 0 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 1 1 0 0 1 174 0 1400 1 1 1 1 OC 0 0 0 0 0 0 0 20 18 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 X JANENE CULUMBER 8137451329 12902 MAGNOLIA DR TAMPA FL 33612 ROBERT ROTHMAN 1.00 X X 0 0 0 SENATOR CONNIE MACK 1.00 X X 0 0 0 TIMOTHY J ADAMS 1.00 X X 0 0 0 DONALD D BUCHANAN 1.00 X X 0 0 0 CARLOS ALFONSO 1.00 X 0 0 0 JORGE ARRIZURIETA 1.00 X 0 0 0 ANGELA BIEVER 1.00 X 0 0 0 THE HONORABLE CARL CARPENTER JR 1.00 X 0 0 0 THEODORE J COUCH SR 1.00 X 0 0 0 EDWARD C DROSTE 1.00 X 0 0 0 CECELIA D FERMAN 1.00 X 0 0 0 JUDY L GENSHAFT PHD 1.00 X 0 0 0 THE HONORABLE JOHN A GRANT 1.00 X 0 0 0 THE HONORABLE JAMES T HARGRETT 1.00 X 0 0 0 REVEREND MONSIGNOR LAURENCE HIGGINS 1.00 X 0 0 0 BENJAMIN H HILL III ESQ 1.00 X 0 0 0 BETH A HOUGHTON 1.00 X 0 0 0 RHEA F LAW ESQ 1.00 X 0 0 0 GARY W LITMAN PHD 1.00 X 0 0 0 THE HONORABLE H LEE MOFFITT 1.00 X 0 0 0 WILLIAM S DALTON 40.00 X 1032396 0 40756 LOUIS D DE LA PARTE 40.00 X 385088 0 39756 JOHN A KOLOSKY 40.00 X 667836 0 47071 ALAN F LIST 40.00 X 0 522633 43375 JAMES J MULE 40.00 X 397585 0 36802 WARREN J PLEDGER 40.00 X 497510 0 42256 NICOLAS C PORTER 40.00 X 487527 0 54177 THOMAS A SELLERS 40.00 X 463530 0 49455 DANIEL M SULLIVAN 40.00 X 0 485937 38343 TIMOTHY J YEATMAN 40.00 X 0 801633 44455 BRAULIO VICENTE JR 40.00 X 142875 135053 42453 MICHAEL K BENEDICT 40.00 X 234939 0 32997 JANENE CULUMBER 40.00 X 289872 0 32816 ANNE L GOFF 40.00 X 196164 0 24771 B LEE GREEN 40.00 X 226234 0 32084 DEAN R HEAD 40.00 X 92485 63725 19169 MARK F HULSE 40.00 X 197311 0 5136 YVETTE LYONS TREMONTI 40.00 X 249143 0 29459 W J WILSON 40.00 X 0 234346 24634 LYNN C MOSCINSKI 40.00 X 0 440204 32059 JIN O CHENG 40.00 X 240623 0 34308 JULIE Y DJEU 40.00 X 289246 0 25602 ROBERT J GILLIES 40.00 X 309483 0 33061 ANNA R GIULIANO 40.00 X 274505 0 39264 SAID M SEBTI 40.00 X 443374 0 44455 W MICHAEL ALBERTS 40.00 X 0 372270 44337 7117726 3055801 933051 94 1 1 0 SHUMAKER LOOP & KENDRICK LLP 101 E KENNEDY BLVD STE 2800 TAMPA FL 33602 LEGAL SERVICES 1531379 DELOITTE CONSULTING LLP 4022 SELLS DRIVE HERMITAGE TN 37076 CONSULTING SERVICES 369988 THEO EXECUTIVE GROUP LLC 909 LAKE CAROLYN PKWY STE 775 IRVING TX 75039 ADVISORY SERVICES 296481 FORD & HARRISON LLP 101 E KENNEDY BLVD STE 900 TAMPA FL 33602 LEGAL SERVICES 173437 SMITH & HOPEN PA 180 PINE AVE N OLDSMAR FL 34677 LEGAL SERVICES 141773 7 9838829 69204496 15056094 851056 94099419 REIMBURSEMENTS 541900 3691373 3691373 3691373 9453 9453 95226 95226 40445 -40445 -40445 -40445 SERIES 2002B BONDS 523000 218381 218381 SERIES 2002A BONDS 523000 139576 139576 LICENSE FEES 541700 132927 132927 42103 42103 532987 98388013 3786599 42103 459892 20550 20550 7231819 2713152 4518667 54209562 42875836 11333726 3704071 2748412 955659 6085006 4509247 1575759 3811131 2827851 983280 2458341 2458341 76600 76600 3155793 2609833 545960 63546 63546 10899718 9871598 1028120 677811 677811 4705026 3424290 1280736 887434 660210 227224 1181465 1181465 12619353 9184289 3435064 PURCHASED SERVICES 5748529 5453549 294980 SUBCONTRACTS 4687334 4687334 0 EDUCATION EXPENSES 750000 0 750000 DUES & SUBSCRIPTIONS 599127 337144 261983 CLINICAL TRIALS 349603 349603 877542 574822 302720 124799361 94770542 30028819 0 2493161 24075841 3998785 5561658 8300899 29413 244062 11155281 12953089 202356013 79213576 130848231 123142437 136953393 113805935 287041137 286521048 49958573 58629711 124610 61706 204766999 194914577 254850182 253605994 X -28645331 -13483817 60836286 46398871 32190955 32915054 287041137 286521048 X 0 1 1 X 1 1 X 72414548 94377844 112810991 116278541 94099419 489981343 72414548 94377844 112810991 116278541 94099419 489981343 489981343 479281 448766 605108 419553 104679 2057387 4830 42103 46933 673220 495315 598727 675538 490884 2933684 495019347 9155637 0.98980 0.98730 X Schedule A, Part IV, Supplemental Information: SCHEDULE A, PART II, LINE 10, EXPLANATION FOR OTHER INCOME: OTHER INCOME IS RELATED TO SERIES 2002A AND SERIES 2002B BONDS AS WELL AS LICENSE FEES. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 0 0 0 1 22257 0 0 22257 0 Part II-B, Line 1i: Explanation of Other Lobbying Activities: THE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS THREE NON-PROFIT SUBSIDIARY CORPORATIONS ("CORPORATION") WERE CREATED TO GOVERN AND OPERATE THE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE ("INSTITUTE") PURSUANT TO SECTION 1004.43, FLORIDA STATUTES. AMONG OTHER THINGS, SECTION 1004.43, FLORIDA STATUTES PROVIDES: (1) THAT THE CORPORATION SHALL ENTER INTO AN AGREEMENT WITH THE STATE BOARD OF EDUCATION FOR THE UTILIZATION OF FACILITIES ON THE CAMPUS OF THE UNIVERSITY OF SOUTH FLORIDA; (2) THAT THE CORPORATION SUBMIT ANNUAL POST AUDITS OF ITS FINANCIAL ACCOUNTS TO THE AUDITOR GENERAL OF THE STATE OF FLORIDA AND THE BOARD OF GOVERNORS FOR THEIR REVIEW; AND (3) THAT THE CORPORATION'S CEO REPORT TO THE BOARD OF GOVERNORS OR ITS DESIGNEE AND PROVIDE COPIES OF THE INSTITUTE'S ANNUAL REPORT TO THE GOVERNOR OF THE STATE OF FLORIDA, THE CABINET, THE PRESIDENT OF THE SENATE, THE SPEAKER OF THE HOUSE AND THE CHAIR OF THE BOARD OF GOVERNORS. ALTHOUGH THE CORPORATION IS A PRIVATE ENTITY, IT IS NONETHELESS SUBJECT TO THE STATE OF FLORIDA'S PUBLIC RECORDS AND THE PUBLIC MEETINGS LAWS. THE CORPORATION ALSO RELIES ON ANNUAL APPROPRIATIONS BY THE LEGISLATURE OF THE STATE OF FLORIDA AND GRANTS FROM VARIOUS LOCAL, STATE AND FEDERAL AGENCIES FOR OPERATION AND MAINTENANCE OF ITS FACILITIES AND FOR SPECIFIC RESEARCH AND CLINICAL PROGRAMS. FOR THESE REASONS, THE CORPORATION FROM TIME TO TIME ENGAGES LOBBYISTS AND OTHER CONSULTANTS; (1) TO ASSIST IT IN COMPLYING WITH ITS REPORTING REQUIREMENTS TO THE STATE OF FLORIDA UNDER SECTION 1004.43, FLORIDA STATUTES; (2) TO MONITOR LEGISLATIVE AND EXECUTIVE BRANCH ACTION AT LOCAL, STATE AND FEDERAL LEVELS OF GOVERNMENT WHICH IMPACT ITS OPERATION AND THE FULFILLMENT OF ITS MISSION; AND (3) TO INFLUENCE LEGISLATION IN FURTHERANCE OF ITS MISSION IN THE AREAS OF CANCER RESEARCH AND TREATMENT, THE TEACHING AND TRAINING OF HEALTH CARE PROFESSIONALS AND COMMUNITY EDUCATION AND OUTREACH ACTIVITIES. THE CORPORATION DOES NOT ENGAGE IN ANY ACTIVITIES TO SUPPORT OR OPPOSE ANY CANDIDATE FOR PUBLIC OFFICE. 9306184 9306184 111952690 33149867 78802823 116193 70926 45267 79362175 45992783 33369392 1618771 1618771 123142437 BOND ISSUE COSTS 1190878 INTEREST IN NET ASSETS OF FOUNDATION 20847000 ASSETS WHOSE USE IS LIMITED 91263240 OTHER ASSETS 4717 INVESTMENT IN MTC 500000 INVESTMENT IN M2GEN 100 113805935 Part X: Description of Uncertain Tax Positions Under FIN 48: THE CANCER CENTER RECOGNIZES UNCERTAIN TAX POSITIONS WHEN IT IS MORE LIKELY THAN NOT (I.E., GREATER THAN 50% LIKELIHOOD OF RECEIVING BENEFIT) AND RECORDS THESE BENEFITS AT THE AMOUNT MOST LIKELY TO BE REALIZED ASSUMING A REVIEW BY TAX AUTHORITIES HAVING ALL RELEVANT INFORMATION AND APPLYING CURRENT CONVENTIONS. THE CANCER CENTER HAS NO SIGNIFICANT UNRECOGNIZED TAX BENEFITS AND DOES NOT BELIEVE THAT THERE WILL BE ANY MATERIAL CHANGES IN THE CANCER CENTER'S UNRECOGNIZED TAX POSITION OVER THE NEXT 12 MONTHS. 1 X Procedure for Monitoring Grants in the U.S.: Part I, Line 2: Schedule I, Part I, Line 2: SPONSORSHIPS AND CHARITABLE CONTRIBUTIONS ARE APPROVED THROUGH THE CHECK REQUEST PROCESS. BECAUSE OF THE NATURE OF THE GRANTS, THE GRANT USE IS NOT MONITORED SINCE THEY ARE GIVEN TO THE ORGANIZATION FOR A SPECIFIC PURPOSE OR EVENT. X X X 0 1 X X X X X 0 0 0 0 0 0 0 0 0 WILLIAM S DALTON 894794 0 0 0 137602 0 25603 0 23102 0 1081101 0 0 0 LOUIS D DE LA PARTE 383304 0 0 0 1784 0 25603 0 16522 0 427213 0 0 0 JOHN A KOLOSKY 518538 0 0 0 149298 0 25603 0 27641 0 721080 0 0 0 ALAN F LIST 0 493050 0 10072 0 19511 0 25602 0 25436 0 573671 0 0 JAMES J MULE 371515 0 0 0 26070 0 24148 0 19028 0 440761 0 0 0 WARREN J PLEDGER 438731 0 0 0 58779 0 25603 0 27842 0 550955 0 0 0 NICOLAS C PORTER 425486 0 0 0 62041 0 25603 0 32492 0 545622 0 0 0 THOMAS A SELLERS 424448 0 0 0 39082 0 25602 0 31866 0 520998 0 0 0 DANIEL M SULLIVAN 0 407444 0 0 0 78493 0 25602 0 23186 0 534725 0 0 TIMOTHY J YEATMAN 0 530124 0 235587 0 35922 0 25603 0 26034 0 853270 0 0 BRAULIO VICENTE JR 135614 131902 0 0 7261 3151 11694 7906 14049 12037 168618 154996 0 0 MICHAEL K BENEDICT 233157 0 0 0 1782 0 19374 0 20845 0 275158 0 0 0 JANENE CULUMBER 273308 0 0 0 16564 0 19600 0 17584 0 327056 0 0 0 ANNE L GOFF 124539 0 0 0 71625 0 8298 0 19890 0 224352 0 0 0 B LEE GREEN 203865 0 0 0 22369 0 18021 0 25816 0 270071 0 0 0 DEAN R HEAD 91351 62894 1134 831 0 0 7496 5153 5397 3957 105378 72835 0 0 MARK F HULSE 134073 0 37120 0 26118 0 1327 0 5716 0 204354 0 0 0 YVETTE LYONS TREMONTI 230149 0 0 0 18994 0 19549 0 18588 0 287280 0 0 0 W J WILSON 0 224904 0 0 0 9442 0 18114 0 11046 0 263506 0 0 LYNN C MOSCINSKI 0 358623 0 47387 0 34194 0 25603 0 12612 0 478419 0 0 JIN O CHENG 219008 0 7293 0 14322 0 25279 0 12551 0 278453 0 0 0 JULIE Y DJEU 269041 0 711 0 19494 0 25602 0 1547 0 316395 0 0 0 ROBERT J GILLIES 306640 0 0 0 2843 0 22078 0 16523 0 348084 0 0 0 ANNA R GIULIANO 223032 0 49000 0 2473 0 25603 0 20178 0 320286 0 0 0 SAID M SEBTI 367717 0 52886 0 22771 0 25602 0 20662 0 489638 0 0 0 W MICHAEL ALBERTS 0 318833 0 0 0 53437 0 25603 0 25289 0 423162 0 0 Part I, Line 1b PAYMENTS MADE FOR SOCIAL CLUB DUES, PERSONAL SERVICES AND PAYMENT WHICH ARE GROSSED UP ARE APPROVED BY THE JOINT EXECUTIVE COMPENSATION AND BENEFITS COMMITTEE (JEC&BC). PAYMENTS ARE A FIXED AMOUNT BASED ON JOB CLASSIFICATION AND IS DOCUMENTED IN MINUTES OF THE COMMITTEE AND REPORTED BACK TO THE BOARD. HILLSBOROUGH COUNTY INDUSTRIAL DEVELOPMENT AUTHORITY 591293512 43233ADJ2 2007-11-08 118550173 SEE SCHED O 0 0 123053888 23235230 11904430 1028820 86885408 0 0 0 0 0 0 0 0 1 0.00000 0.00000 0.00000 1 0 0 0 1 SUNTRUST 9.100000000000 1 0 0 H Lee Moffitt LEASE OF OFFICE SPACE IN TALLAHASSEE 1 4490 0 FOWLER WHITE BOGGS VENDOR OF INSTITUTE ORGANIZATION 120276 SEE SCHED O 0 X EQUIPMENT 90 851056 PURCHASE PRICE 0 0 0 0 Method for Determining Number of Contributors: Part I, Column (b): THE NUMBER OF CONTRIBUTORS REPORTED REFLECTS THE NUMBER OF ITEMS CONTRIBUTED. Form 990, Part VI, Section B, line 11 PRIOR TO PROVIDING FORM 990, RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX, TO THE PARENT-RESEARCH BOARD OF DIRECTORS FOR REVIEW, THE CHIEF FINANCIAL OFFICER REVIEWS THE RETURN. SUGGESTED COMMENTS OR CHANGES ARE DISCUSSED AND ANY NECESSARY CORRECTIONS ARE MADE. PRIOR TO ELECTRONICALLY FILING FORM 990, MOFFITT PARENT-RESEARCH PROVIDES A COPY OF THE RETURN TO THE GOVERNING BODY, GIVING EACH BOARD MEMBER TIME TO REVIEW THE RETURN. BOARD MEMBERS HAVE THE OPPORTUNITY TO ASK QUESTIONS RELATED TO THE INFORMATION PROVIDED ON THE RETURN. Form 990, Part VI, Section B, line 12c ON AN ANNUAL BASIS A PRESENTATION IS MADE TO RESEARCH BOARD MEMBERS TO REVIEW THE CONFLICT OF INTEREST POLICY AND PROCEDURES FOR DISCLOSING ANY POTENTIAL CONFLICTS. EACH DIRECTOR, OFFICER, COMMITTEE MEMBER, AND KEY EMPLOYEE SHALL COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM ATTACHED TO THE POLICY. ANY DIRECTOR, OFFICER, COMMITTEE MEMBER, OR KEY EMPLOYEE WHO REASONABLY BELIEVES THAT HE OR SHE MAY HAVE AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST MUST DISCLOSE THE EXISTENCE OF AND THE MATERIAL FACTS OF THE NATURE OF HIS/HER INTEREST ON THE FORM. THE FORM IS SUBMITTED TO THE CORPORATE COMPLIANCE OFFICE, WHICH REVIEWS THE FORMS, GATHERS ADDITIONAL RELEVANT INFORMATION WHERE NECESSARY, AND PREPARES A SUMMARY OF THE DISCLOSURES TO BE REVIEWED BY THE CONFLICT OF INTERST WORK GROUP. IF A DIRECTOR OR COMMITTEE MEMBER DISCLOSES THAT HE/SHE HAS A POTENTIAL CONFLICT OF INTEREST AT A BOARD OR COMMITTEE MEETING, SUCH DIRECTOR OR COMMITTEE MEMBER MUST DISCLOSE THE NATURE OF THE INTEREST AND ANY RELATED INFORMATION AND RESPOND TO QUESTIONS AS MAY BE REQUIRED BY THE REMAINING MEMBERS. BASED ON THE INFORMATION DISCLOSED, THE REMAINING BOARD MEMBERS WILL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS. IF A CONFLICT EXISTS THE BOARD OR COMMITTEE SHALL DETERMINE WHETHER AN ALTERNATIVE TRANSACTION OR ARRANGEMENT THAT WOULD NOT GIVE RISE TO A CONFLICT IS EQUALLY ADVANTAGEOUS. IF AN ALTERNATIVE TRANSACTION IS NOT EQUALLY ADVANTAGEOUS THE DIRECTOR OR COMMITTEE MEMBER WHO IS THE SUBJECT OF THE CONFLICT SHALL NOT VOTE ON, NOR USE HIS/HER PERSONAL INFLUENCE ON, NOR PARTICIPATE IN DISCUSSIONS OR DELIBERATIONS WITH RESPECT TO THE TRANSACTION. Form 990, Part VI, Section B, line 15 MOFFITT'S BOARD OF DIRECTORS HAS AN ESTABLISHED SUB-COMMITTEE, THE JOINT EXECUTIVE COMPENSATION & BENEFITS COMMITTEE (JEC&BC) THAT IS MADE UP ENTIRELY OF INDEPENDENT, OUTSIDE DIRECTORS. THIS COMMITTEE IS CHARGED WITH THE OVERSIGHT OF THE PERFORMANCE AND COMPENSATION OF MOFFITT EXECUTIVES AND DISQUALIFIED PERSONS. THESE POSITIONS INCLUDE THE CEO, EXECUTIVE VICE PRESIDENTS, SENIOR VICE PRESIDENTS, VICE PRESIDENTS AND DEPARTMENT CHAIRPERSONS. TO ACCOMPLISH ITS MISSION, THE COMMITTEE CAN AS NEEDED AND DOES AT ITS DISCRETION, ENGAGE OUTSIDE INDEPENDENT, OUTSIDE ADVISORS INCLUDING, BUT NOT LIMITED TO ATTORNEYS AND COMPENSATION CONSULTANTS. ON AN ANNUAL BASIS THE JEC&BC ENGAGES A NATIONALLY KNOWN, THIRD PARTY CONSULTING FIRM TO PROVIDE A DETAILED STUDY OF THE CASH COMPENSATION FOR EACH EXECUTIVE, DISQUALIFIED PERSON AND INDIVIDUAL IN KEY POSITIONS. THE CONSULTANT USES A VARIETY OF PUBLISHED SURVEYS COMPILED BY INDEPENDENT FIRMS TO PROVIDE THE SOURCE DATA FOR THE STUDY. USING FUNCTIONALLY COMPARABLE POSITIONS IN OTHER SIMILARLY SIZED, NOT-FOR-PROFIT AND FOR-PROFIT HEALTHCARE, ACADEMIC AND RESEARCH ORGANIZATIONS, THE CONSULTING FIRM PRODUCES A STUDY THAT COMPARES EACH DESIGNATED MOFFITT POSITION TO ITS APPROPRIATE MARKET EQUIVALENT. THE RESULTING DATA IS PROVIDED TO THE DIRECTOR OF COMPENSATION, WHO IS NOT INCLUDED IN THE EXECUTIVE OR DISQUALIFIED PERSON CATEGORIES, FOR USE IN THE FORMULATION OF RECOMMENDATIONS FOR COMPENSATION CHANGES TO MAINTAIN MARKET COMPETITIVENESS OR TO REWARD PERFORMANCE. THESE RECOMMENDATIONS ALONG WITH THE CONSULTANT'S COMPARABILITY DATA ARE PRESENTED TO THE JEC&BC FOR IT TO CONFIRM ITS REASONABLENESS, MAKE MODIFICATIONS AS IT DEEMS NECESSARY AND PROVIDE FINAL APPROVAL. EVERY THIRD YEAR THE INDEPENDENT CONSULTANT ANALYZES THE TOTAL EXECUTIVE COMPENSATION PROGRAM, USING THE SAME METHODOLOGY AS DESCRIBED ABOVE, THAT INCLUDEDS THE VALUE OF ALL BENEFITS AND PREREQUISITES (CASH AND NON-CASH) PROVIDED AS COMPENSATION TO THE EXECUTIVES AND DISQUALIFIED PERSONS. THE PURPOSE OF THE ANALYSIS IS TO PROVIDE AN OPINION ON THE REASONABLENESS OF EACH OF THE INDIVIDUAL COMPENSATION COMPONENTS AND THE AGGREGATE COMPENSATION TOTAL. THIS MORE COMPREHENSIVE ANALYSIS IS PROVIDED TO THE JEC&BC FOR THEIR USE IN THE ANNUAL REVIEW PROCESS. MINUTES ARE KEPT AT EACH OF THESE ANNUAL MEETINGS DETAILING THE RECOMMENDATIONS PRESENTED AND THE DECISIONS MADE BY THE COMMITTEE. THESE MINUTES ARE PUBLISHED TO THE COMMITTEE AT THE NEXT MEETING AND REPORTED BACK TO THE FULL BOARD. Form 990, Part VI, Section C, line 19 MOFFITT RESEARCH MAKES AVAILABLE TO THE PUBLIC THROUGH THIRD PARTY VENDORS' WEBSITES, ITS FORM 990 AND AUDITED FINANCIAL STATEMENTS. FORM 990 IS MADE AVAILABLE ON GUIDESTAR WHILE THE AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE ON DACBOND. ALL ORGANIZING AND GOVERNING DOCUMENTS SUCH AS FORM 1023, CONFLICTS OF INTEREST POLICY, AND BYLAWS AS WELL AS FORM 990 AND AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. Form 990, Part VII, Section A, Line 1a: THE INSTITUTE FILES W-2'S FOR ALL NON-PROFIT RELATED ENTITIES. HOWEVER, FOR PURPOSES OF FILING FORM 990, EMPLOYEES ARE REPORTED BY THE NON-PROFIT ENTITY FOR WHICH THEY WORK WHICH IS A MORE CONSERVATIVE APPROACH, SINCE CERTAIN KEY EMPLOYEES COULD POTENTIALLY BE EXCLUDED SINCE THEY WOULD NOT BE KEY EMPLOYEES OF THE INSTITUTE. PROCEDURES TO REPORT COMPENSATION OF THESE EMPLOYEES ON FORM 990 PART VII AND ON SCHEDULE J, FOR EACH RESPECTIVE ENTITY, ARE IN ACCORDANCE WITH IRS INSTRUCTIONS. IN ADDITION, SEVERAL OFFICERS LISTED IN PART VII SECTION A ARE ALSO OFFICERS OF A RELATED ORGANIZATION AND THEIR HOURS ARE TRACKED AND SALARIES PAID BY A RELATED ORGANIZATION. THESE HOURS AND SALARIES ARE NOT SPECIFICALLY ALLOCATED BETWEEN THE ORGANIZATIONS FOR THESE OFFICERS SINCE THEIR DUTIES AND RESPONSIBILITIES IMPACT THE ORGANIZATION(S) AS A WHOLE. PART VII SECTION A LINE 1 AND SCHEDULE J: DR. TIMOTHY YEATMAN'S COMPENSATION INCLUDES WAGES FOR TWO INDEPENDENT ROLES WITH INDEPENDENT RESPONSIBILITIES AS EXECUTIVE VICE PRESIDENT FOR TRANSLATIONAL RESEARCH AT MOFFITT CANCER CENTER AND CHIEF SCIENTIFIC OFFICER AT THE SUBSIDIARY COMPANY, MOFFITT GENETICS CORPORATION (M2GEN). SCHEDULE K PART I: DESCRIPTION OF PURPOSE: PURPOSE OF USE OF FUNDS RELATES TO THE CONSTRUCTION OF A BUILDING FOR ADDITIONAL PATIENT BEDS, RADIATION ONCOLOGY, LABS, AND OFFICES. IN ADDITION FUNDS WILL BE USED TO CONSTRUCT A PARKING STRUCTURE AND VARIOUS BACKFILL PROJECTS. SCHEDULE K PART II LINE 8: SUBSTANTIAL COMPLETION DATE FOR PROJECT IS ESTIMATED TO BE IN 2012. SCHEDULE L PART IV: INSTITUTE CONTRACTS FOWLER WHITE BOGGS FOR LEGAL SERVICES FOR WHICH RHEA LAW, AN INSTITUTE BOARD MEMEBER, IS THE CEO AND CHAIR OF THE BOARD. Form 990, Part VII, Section A, Line 1a: FOR TAX YEAR 2009 MOFFITT'S EXECUTIVE COMMITTEE HELD AUTHORITY TO ACT ON THE GOVERNING BODY'S BEHALF. THE COMMITTEE CONSISTS OF ELEVEN VOTING MEMBERS AND ONE NON-VOTING MEMBER. MOST OF THE EXECUTIVE COMMITTEE'S VOTING MEMBERS ARE MEMBERS OF H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE'S GOVERNING BOARD. THE SCOPE OF THE COMMITTEE'S POWERS ARE AS FOLLOWS: THE COMMITTEE SHALL REVIEW THE BOARD OF DIRECTORS' ANNUAL PERFORMANCE EVALUATION AND SHALL HAVE AND MAY EXERCISE ALL POWERS OF THE BOARD EXCEPT THE POWER TO: (i) FILL VACANCIES ON THE BOARD OR ANY OTHER COMMITTEE THEREOF; (ii) AMEND EITHER THE ARTICLES OF INCORPORATION OR BYLAWS OF THE CORPORATION; (iii) ADOPT A PLAN OF MERGER, CONSOLIDATION, RECAPITALIZATION, OR OTHER FORMS OF REORGANIZATION; (iv) SELL, LEASE, EXCHANGE, OR OTHERWISE DISPOSE OF ALL OR SUBSTANTIALLY ALL OF THE PROPERTY AND ASSETS OF THE CORPORATION; (v) ADOPT A PLAN OF VOLUNTARY DISSOLUTION OF THE CORPORATION; OR (vi) EXERCISE ANY OTHER POWERS SPECIFICALLY RESERVED TO THE BOARD AS A WHOLE. THE COMMITTEE SHALL REPORT ITS ACTIONS TO THE BOARD AT THE BOARD'S NEXT REGULARLY SCHEDULED MEETING, WHICH SHALL BE DULY NOTED IN THE MINUTES OF THE PROCEEDINGS OF THE BOARD. PART V LINE 4B: INSTITUTE HAS AN INTEREST IN POOLED INVESTMENTS IN FOREIGN COUNTRIES ACTIVELY MANAGED BY DOMESTIC FUND MANAGERS THROUGH INSTITUTE'S BANKING RELATIONSHIPS AND BUSINESS RELATIONSHIPS WITH INVESTMENT COMPANIES. INVESTMENT INFORMATION IS NOT SEGREGATED BY COUNTRY ON POOLED INVESTMENTS. H LEE MOFFITT CC&RI HOSPITAL INC 12902 MAGN0LIA DRIVE TAMPA FL 33612 593238634 PATIENT CARE FL 501(C)(3) 509(A)(1) N/A H LEE MOFFITT CC&RI FOUNDATION INC 12902 MAGN0LIA DRIVE TAMPA FL 33612 593238636 FUNDRAISING FL 501(C)(3) 509(A)(2) N/A H LEE MOFFITT CC&RI LIFETIME CANCER SCREENING CENTER INC 12902 MAGN0LIA DRIVE TAMPA FL 33612 593238640 PRACTICE MANAGEMENT FL 501(C)(3) 509(A)(2) N/A MOFFITT TECHNOLOGIES CORPORATION 12902 MAGNOLIA DRIVE TAMPA FL 33612 300332914 TECHNOLOGY MANAGEMENT FL H LEE MOFFITT CC&RI INC C 505904 1.00000 MOFFITT GENETICS CORPORATION 12902 MAGNOLIA DRIVE TAMPA FL 33612 208486180 DATABASE MANAGEMENT FL H LEE MOFFITT CC&RI INC C -769 5860789 1.00000 0 0 1 1 0 0 0 0 1 0 0 0 0 0 1 1 0 0 MOFFITT GENETICS CORPORATION C 1009784 MOFFITT GENETICS CORPORATION D 4657917 MOFFITT TECHNOLOGIES CORPORATION D 241797 MOFFITT GENETICS CORPORATION I 490605 MOFFITT TECHNOLOGIES CORPORATION O 77412 MOFFITT GENETICS CORPORATION O 3700631 MOFFITT GENETICS CORPORATION P 971265